Dier Mardi's Form 4 filing
Madrigal Pharmaceuticals, Inc. (MDGL) · filed Mar 5, 2025
- Accession no.
- 0001628280-25-010508
- Filed
- Mar 5, 2025
- Trade date
- Mar 3, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $637.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dier MardiCIK 0001574591 | Officer (SVP and CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Common Stock | SSaleDisposed | −1,187 | $325.89 | −$386,831.43 | 7,688 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −774 | $323.54 | −$250,419.96 | 6,914 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.